Revive Therapeutics Ltd: MDA EN

SEDAROct 29 08:19 · Announcements

Revive Therapeutics Ltd: AUDITED ANNUAL FINANCIAL STATEMENTS EN

SEDAROct 29 06:42 · Announcements

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

MT NewswiresApr 2 20:31

Revive Therapeutics Submits Type C Meeting Request Package to FDA for Clinical Study of Bucillami...

Stockhouse Mar 27 21:08

Revive Therapeutics to Submit Type C Meeting Request With FDA for Bucillamine to Treat Long COVID

MT NewswiresMar 19 20:26

Revive Therapeutics To Submit Type C Meeting Request With FDA for Bucillamine to Treat Long COVID

Stockhouse Mar 19 19:00